In NAFLD, lysosomal dysfunction leads to reduced activity of lysosomal acid lipase (LAL), an enzyme hydrolyzing cholesterol esters and triglycerides. The gene discussed is LIPA; the disease is metabolic dysfunction-associated steatotic liver disease.